US EditionPublished • loading... • Updated
Pacira BioSciences Appoints Samit Hirawat, M.D., to Board of Directors – Ortho Spine News
— Veteran Executive Brings More Than 25 Years of Clinical Development and Industry Expertise — BRISBANE, Calif., Jan. 28, 2026 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced the appointment of Samit Hirawat, M.D., to its Board of Directors. This appointment increases the size of the company’s Boar
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Pacira BioSciences Appoints Samit Hirawat, M.D., to Board of Directors – Ortho Spine News
— Veteran Executive Brings More Than 25 Years of Clinical Development and Industry Expertise — BRISBANE, Calif., Jan. 28, 2026 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced the appointment of Samit Hirawat, M.D., to its Board of Directors. This appointment increases the size of the company’s Boar
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
